Tensor Bio
- Diagnostics
- Other R&D services
- IT, information
Tensor Bio is a precision diagnostics company revolutionizing metabolic liver disease care with non-invasive, AI-powered cfDNA testing. Founded by Stanford researchers, the company’s lead product, MASH Select™, delivers accurate, accessible staging of MASH and MASLD to support earlier detection, more personalized care, and smarter use of emerging therapeutics. By replacing invasive and often inconclusive diagnostic methods, Tensor empowers physicians to take action sooner and helps unlock the full potential of next-generation liver disease treatments to improve outcomes and save lives. MASH IQ™ is Tensor Bio's precision blood testing service, that helps biopharma partners identify and monitor patients with MASH, enabling smarter trial enrolment and treatment response tracking.